Merck: Consolidating 12 Siloed Solutions to a Single Platform with CARA
Merck, described on the page as the world's oldest pharmaceutical company, faced complexity from multiple disconnected systems across Quality, Regulatory, Safety, and Clinical operations. It implemented the CARA Life Sciences Platform to unify these environments, consolidating 12 separate systems into one integrated platform managing 18 million documents for 85,000 users. The page frames this as enabling streamlined workflows and unified data management across these business functions.
Generis makes the CARA platform, the regulatory/quality/clinical content backbone used by major pharma companies, now with AI document-classification features built in.
This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.
Published by Generis on its own site — read the original case study on caralifesciences.generiscorp.com ↗
Related use cases
- 01Replacing Legacy Systems at Scale: Bayer's Global Migration to the CARA Platform
- 02Global Pharma Modernises Archiving with CARA Platform
- 03Swixx Biopharma Consolidates QMS, RIM, and Safety Processes on the CARA Life Sciences Platform
- 04Cheplapharm: Pharma Company Unify Processes with the CARA Life Sciences Platform
- 05Pfizer Case Study
- 06Transforming Content Operations for 2x Faster Time to Market